Login / Signup

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders.

Jennifer LaJulie Tsu-Yu WuWestyn Branch-EllimanBrittany L HuhmannSummer S HanMary BrophyNhan V DoAlbert Y LinNathanael R FillmoreNikhil C Munshi
Published in: Blood (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • single cell
  • cell therapy
  • stem cells
  • respiratory syndrome coronavirus
  • bone marrow